Article Versions Notes

ElShagea HN, Makar RR, Salama AH, Elkasabgy NA, Basalious EB. Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease. Pharmaceutics. 2023; 15(2):533. https://doi.org/10.3390/pharmaceutics15020533

ElShagea, Hala N., Rana R. Makar, Alaa H. Salama, Nermeen A. Elkasabgy, and Emad B. Basalious. 2023. "Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease" Pharmaceutics 15, no. 2: 533. https://doi.org/10.3390/pharmaceutics15020533

ElShagea, H. N., Makar, R. R., Salama, A. H., Elkasabgy, N. A., & Basalious, E. B. (2023). Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease. Pharmaceutics, 15(2), 533. https://doi.org/10.3390/pharmaceutics15020533